Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating Costs and Expenses:
General and administrative	$ 2,687	$ 1,541	$ 4,888	$ 3,196
Research and development	3,133	3,485	6,110	6,082
Total Operating Costs and Expenses	5,820	5,026	10,998	9,278
Loss from Operations	(5,820)	(5,026)	(10,998)	(9,278)
Other Expense:
Exchange loss	(4)	(9)	1	(31)
Interest income	381	26	745	27
Total Other Income(Expense)	377	17	746	(4)
Net Loss	(5,443)	(5,009)	(10,252)	(9,282)
Income tax benefit	359	532	689	532
Net Loss Attributable to Common Stockholders	$ (5,084)	$ (4,477)	$ (9,563)	$ (8,750)
Net Loss Per Share - Basic	$ (0.34)	$ (0.28)	$ (0.63)	$ (0.59)
Net Loss Per Share - Dilutive	$ (0.34)	$ (0.28)	$ (0.63)	$ (0.59)
Weighted average number of shares outstanding during the period - Basic	15,166,209	15,844,061	15,145,252	14,837,832
Weighted average number of shares outstanding during the period - Dilutive	15,166,209	15,844,061	15,145,252	14,837,832
Net Loss	$ (5,084)	$ (4,477)	$ (9,563)	$ (8,750)
Gain(Loss) on foreign currency translation	(51)	(1,442)	323	(1,261)
Total comprehensive loss	$ (5,135)	$ (5,919)	$ (9,240)	$ (10,011)